Neogen Corporation Impairment of Long-Lived Assets Held-for-use
Neogen Corporation (NEOG) reported Impairment of Long-Lived Assets Held-for-use of $1.07 billion for the 12-month period ending 2025-05-31, per its 10-K filed 2025-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2026-07-30
- Neogen Corporation impairment of long-lived assets held-for-use for the quarter ending 2025-02-28 was $2.10M.
- Neogen Corporation impairment of long-lived assets held-for-use for fiscal 2025 was $1.07B.
- Neogen Corporation impairment of long-lived assets held-for-use for fiscal 2024 was $0.00.
- Neogen Corporation impairment of long-lived assets held-for-use for fiscal 2023 was $0.00.
- Neogen Corporation impairment of long-lived assets held-for-use for fiscal 2022 was $0.00.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 3 month as first filed | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|
| 2025-05-31 | $1.07B 10-K · filed 2025-07-30 | ||
| 2025-02-28 | $2.10M 10-K · filed 2026-07-30 | $2.06M 10-Q · filed 2025-04-09 | |
| 2024-05-31 | $0.00 10-K · filed 2025-07-30 | ||
| 2023-05-31 | $0.00 10-K · filed 2025-07-30 | ||
| 2022-05-31 | $0.00 10-K · filed 2023-08-15 | ||
| 2021-05-31 | $0.00 10-K · filed 2023-08-15 | ||
| 2020-05-31 | $0.00 10-K · filed 2022-07-27 | ||
| 2019-05-31 | $0.00 10-K · filed 2021-07-30 | ||
| 2018-05-31 | $0.00 10-K · filed 2020-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |